Covance, a global contract research organization, worked on all of the top 50 best-selling drugs available today through its full spectrum of nonclinical, clinical and commercialization services.
COVID-19: Impact on Industry Events
We are continuing to monitor which tradeshows have been cancelled, postponed or are now virtual. Click to see the latest updates.
Covance is dedicated to advancing healthcare and delivering Solutions Made Real®
With precision delivery of the largest volume of drug development data on the planet, we can help you identify new approaches and anticipate tomorrow’s challenges. Learn more about our history and services.
Supporting Women Leaders in Healthcare
Paul Kirchgraber, MD, CEO of Covance, was recognized by the AMWA with the Dr. Larry Zaroff Man of Good Conscience Award.
Functional Service Provider (FSPx™)
Our Functional Service Provider model (FSPx™) offers customized global solutions of functional, clinical, technical and laboratory services that are flexible and scalable.
Decentralized Clinical Trials
Connect with More Patients, Virtually Anywhere
Covance decentralized clinical trials: Designed Around You® and your patients
Crop Protection Blog
How to Renew Plant Protection Products – EU Regulations
Understand how global regulators define pesticides and their approval. Our latest blog reviews the steps for renewing existing plant protection active substances in the EU and walks you through the considerations for renewing your agrochemicals. Find out here.
Cell and Gene Therapy Solutions
Learn more about reducing time and risk in your therapeutic's development across pre-clinical, clinical and post-approval phases.
Experienced, Flexible and Proven Program Design and Delivery
Covance Patient Assistance Programs are designed to optimize patient engagement and program qualification with the appropriate use of technology, with built-in program flexibility to evolve with your product throughout its life.
Access Validated Bioanalytical Assays for COVID-19 Treatment
Check out our recently updated nonproprietary assay list featuring more than 330 compounds.
Accelerate Your Speed to Market with Scientific Support from the Biomarker Solution Center
Collaborate on a tailored approach to your biomarker program with a team of PhD-level leaders bringing expertise in key therapeutic areas.
Real-Time Data. Real-World Impact.
Combining four unique data sets with our therapeutic and functional expertise, Covance can impact protocol design and feasibility, optimal site selection, and patient recruitment.
Fixing the Leaky Patient Recruitment Funnel
Watch now to learn innovative, data-driven approaches for improving patient recruitment and retention.
Tools & Technology for Advancing Rare Disease Research and Drug Development
Read about how the role of emerging science, technology and real-world data is allowing for exploring novel methods of data analysis.
Covance Builds on Extensive Cytometry Offering with Innovative Fluidigm CyTOF® Technology
Learn more about our comprehensive flow cytometry solutions
Clinical Data and Informatics
Explore the Xcellerate® Informatics Suite
Successful clinical trials begin and end with the RIGHT data. Uncover new possibilities for your clinical trials with Xcellerate®, a fully integrated informatics platform. ONE comprehensive platform. UNPARALLELED RESULTS.
Bioanalysis Education Center: Covance leads the way in bioanalytical capabilities and solutions, igniting innovation with exceptional science and timely answers.
Access the latest scientific posters, list of non-proprietary/generic assays, publications and info sheets.
Immuno-oncology and the role of biomarkers, companion and complementary diagnostics
Learn more about how the use of a variety of biomarkers, companion diagnostics (CDx) and complementary diagnostics has powered the recent evolution of immunotherapies and their potential applications.